Haijing Zhou

Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

FAM163A, a positive regulator of ERK signaling pathway, interacts with 14-3-3β and promotes cell proliferation in squamous cell lung carcinoma.

FAM163A, a positive regulator of ERK signaling pathway, interacts with 14-3-3β and promotes cell proliferation in squamous cell lung carcinoma.

Journal: OncoTargets and therapy
Published: May 07, 2019

TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.

TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.

Journal: Molecular carcinogenesis
Published: July 08, 2018

ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.

ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: October 20, 2017

Alex3 suppresses non-small cell lung cancer invasion via AKT/Slug/E-cadherin pathway.

Alex3 suppresses non-small cell lung cancer invasion via AKT/Slug/E-cadherin pathway.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 15, 2017

DDIAS promotes invasion and proliferation of non-small cell lung cancer and predicts poor survival of lung cancer patients.

DDIAS promotes invasion and proliferation of non-small cell lung cancer and predicts poor survival of lung cancer patients.

Journal: International journal of clinical and experimental pathology
Published: July 13, 2017

Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.

Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 17, 2017

ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.

ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.

Journal: Oncotarget
Published: January 17, 2017

Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.

Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.

Journal: Molecular carcinogenesis
Published: January 14, 2017

TMEM17 depresses invasion and metastasis in lung cancer cells via ERK signaling pathway.

TMEM17 depresses invasion and metastasis in lung cancer cells via ERK signaling pathway.

Journal: Oncotarget
Published: January 02, 2017

Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway.

Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway.

Journal: Oncotarget
Published: December 08, 2016

CCDC106 promotes non-small cell lung cancer cell proliferation.

CCDC106 promotes non-small cell lung cancer cell proliferation.

Journal: Oncotarget
Published: November 16, 2016

Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.

Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.

Journal: Molecular carcinogenesis
Published: October 26, 2016
Showing 1-12 of 15

Last Updated: 09/26/2026